drugset / Trial / NCT01301313
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy and safety of levosimendan versus conventional intensified inotropic treatment, in critical children with severe acute heart failure which persists despite of having received conventional inotropic treatment.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dobutamine | Small molecule | — | — |
| Comparator | Dopamine | Small molecule | — | — |
| Comparator | Epinephrine | Other / unclassified | — | — |
| Subject | Levosimendan | Other / unclassified | 0.1 ug/kg | Intravenous |
| Subject | Levosimendan | Other / unclassified | 0.2 ug/kg | Intravenous |
| Comparator | Milrinone | Small molecule | — | — |